{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:07:09Z","timestamp":1768514829195,"version":"3.49.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Thailand Science research and Innovation Fund Chulalongkorn University","award":["CU_FRB65_hea (55)_064_33_08"],"award-info":[{"award-number":["CU_FRB65_hea (55)_064_33_08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As a response to invasion by pathogens, the secretion of interleukin 6 (IL-6) which is a cytokine, activates IL-6\/JAKs\/STAT3 intracellular signaling via., phosphorylation. Over expression of pSTAT3 induces IL-6 positive feedback loop causing cytokine release syndrome or cytokine storm. Plants have gained momentum as an alternative expression system. Hence, this study aims to produce mAb targeting human IL-6 receptor (hIL-6R) in <jats:italic>Nicotiana benthamiana<\/jats:italic> for down regulating its cellular signaling thus, decreasing the expression of pSTAT3. The variable regions of heavy and light chains of anti-hIL-6R mAb were constructed in pBYK2e geminiviral plant expression vector and transiently co-expressed in <jats:italic>N. benthamiana<\/jats:italic>. The results demonstrate the proper protein assembly of anti-hIL-6R mAb with highest expression level of 2.24\u00a0mg\/g FW at 5 dpi, with a yield of 21.4\u00a0\u00b5g\/g FW after purification. The purity and N-glycosylation of plant produced antibody was analyzed, including its specificity to human IL-6 receptor by ELISA. Additionally, we investigated the effect to pSTAT3 expression in human PBMC\u2019s by flow cytometry wherein, the results confirmed lower expression of pSTAT3 with increasing concentrations of plant produced anti-hIL-6R mAb. Although, further in vivo studies are key to unveil the absolute functionality of anti-hIL-6R, we hereby show the potential of the plant platform and its suitability for the production of this therapeutic antibody.<\/jats:p>","DOI":"10.1038\/s41598-023-39106-5","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T10:02:24Z","timestamp":1690192944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells"],"prefix":"10.1038","volume":"13","author":[{"given":"Namthip","family":"Kaewbandit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwini","family":"Malla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanuttha","family":"Boonyayothin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaewta","family":"Rattanapisit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thareeya","family":"Phetphoung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuttapat","family":"Pisuttinusart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rattana","family":"Saetung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supannikar","family":"Tawinwung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waranyoo","family":"Phoolcharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"39106_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8, S3. https:\/\/doi.org\/10.1186\/ar1917 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"39106_CR2","doi-asserted-by":"publisher","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","volume":"12","author":"A Santa Cruz","year":"2021","unstructured":"Santa Cruz, A. et al. Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia. Front. Immunol. 12, 613422. https:\/\/doi.org\/10.3389\/fimmu.2021.613422 (2021).","journal-title":"Front. Immunol."},{"key":"39106_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.20190347","volume":"217","author":"S Kang","year":"2020","unstructured":"Kang, S., Narazaki, M., Metwally, H. & Kishimoto, T. Historical overview of the interleukin-6 family cytokine. J. Exp. Med. 217, 347. https:\/\/doi.org\/10.1084\/jem.20190347 (2020).","journal-title":"J. Exp. Med."},{"key":"39106_CR4","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jaci.2020.07.001","volume":"146","author":"A Copaescu","year":"2020","unstructured":"Copaescu, A., Smibert, O., Gibson, A., Phillips, E. J. & Trubiano, J. A. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J. Allergy Clin. Immunol. 146, 518-534.e511. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.001 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"39106_CR5","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.bbamcr.2016.03.018","volume":"1218\u20131227","author":"M Rothaug","year":"1863","unstructured":"Rothaug, M., Becker-Pauly, C. & Rose-John, S. The role of interleukin-6 signaling in nervous tissue. Biochim. Biophys. Acta 1218\u20131227, 2016. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.03.018 (1863).","journal-title":"Biochim. Biophys. Acta"},{"key":"39106_CR6","doi-asserted-by":"publisher","first-page":"e21958","DOI":"10.1096\/fj.202101044RRR","volume":"35","author":"X Luan","year":"2021","unstructured":"Luan, X. et al. Cyclophilin A is a key positive and negative feedback regulator within interleukin-6 trans-signaling pathway. FASEB J. 35, e21958. https:\/\/doi.org\/10.1096\/fj.202101044RRR (2021).","journal-title":"FASEB J."},{"issue":"Pt 2","key":"39106_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj3000281","volume":"300","author":"S Rose-John","year":"1994","unstructured":"Rose-John, S. & Heinrich, P. C. Soluble receptors for cytokines and growth factors: Generation and biological function. Biochem. J. 300(Pt 2), 281\u2013290. https:\/\/doi.org\/10.1042\/bj3000281 (1994).","journal-title":"Biochem. J."},{"key":"39106_CR8","doi-asserted-by":"publisher","first-page":"41974","DOI":"10.18632\/oncotarget.9633","volume":"7","author":"SF Hendrayani","year":"2016","unstructured":"Hendrayani, S. F., Al-Harbi, B., Al-Ansari, M. M., Silva, G. & Aboussekhra, A. The inflammatory\/cancer-related IL-6\/STAT3\/NF-\u03baB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget 7, 41974\u201341985. https:\/\/doi.org\/10.18632\/oncotarget.9633 (2016).","journal-title":"Oncotarget"},{"key":"39106_CR9","doi-asserted-by":"publisher","first-page":"760971","DOI":"10.3389\/fonc.2021.760971","volume":"11","author":"J Xu","year":"2021","unstructured":"Xu, J., Lin, H., Wu, G., Zhu, M. & Li, M. IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front. Oncol. 11, 760971. https:\/\/doi.org\/10.3389\/fonc.2021.760971 (2021).","journal-title":"Front. Oncol."},{"key":"39106_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.molimm.2020.10.006","volume":"128","author":"JJ Guirao","year":"2020","unstructured":"Guirao, J. J., Cabrera, C. M., Jim\u00e9nez, N., Rinc\u00f3n, L. & Urra, J. M. High serum IL-6 values increase the risk of mortality and the severity of pneumonia in patients diagnosed with COVID-19. Mol. Immunol. 128, 64\u201368. https:\/\/doi.org\/10.1016\/j.molimm.2020.10.006 (2020).","journal-title":"Mol. Immunol."},{"key":"39106_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"39106_CR12","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","volume":"13","author":"M Sheppard","year":"2017","unstructured":"Sheppard, M., Laskou, F., Stapleton, P. P., Hadavi, S. & Dasgupta, B. Tocilizumab (Actemra). Hum. Vaccin. Immunother. 13, 1972\u20131988. https:\/\/doi.org\/10.1080\/21645515.2017.1316909 (2017).","journal-title":"Hum. Vaccin. Immunother."},{"key":"39106_CR13","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/ijms22063059","volume":"22","author":"C Pelaia","year":"2021","unstructured":"Pelaia, C. et al. Therapeutic role of tocilizumab in SARS-CoV-2-induced cytokine storm: Rationale and current evidence. Int. J. Mol. Sci. 22, 3059 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"39106_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/conmed-2018-000002","volume":"2","author":"T Takeuchi","year":"2018","unstructured":"Takeuchi, T. et al. Considering new lessons about the use of IL-6 inhibitors in arthritis. Consid. Med. 2, 7\u201311. https:\/\/doi.org\/10.1136\/conmed-2018-000002 (2018).","journal-title":"Consid. Med."},{"key":"39106_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40744-018-0102-x","volume":"5","author":"A Rubbert-Roth","year":"2018","unstructured":"Rubbert-Roth, A., Furst, D. E., Nebesky, J. M., Jin, A. & Berber, E. A review of recent advances using tocilizumab in the treatment of rheumatic diseases. Rheumatol. Therapy 5, 21\u201342. https:\/\/doi.org\/10.1007\/s40744-018-0102-x (2018).","journal-title":"Rheumatol. Therapy"},{"key":"39106_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1093\/carcin\/bgab102","volume":"42","author":"N Al-Jomah","year":"2021","unstructured":"Al-Jomah, N., Al-Mohanna, F. H. & Aboussekhra, A. Tocilizumab suppresses the pro-carcinogenic effects of breast cancer-associated fibroblasts through inhibition of the STAT3\/AUF1 pathway. Carcinogenesis 42, 1439\u20131448. https:\/\/doi.org\/10.1093\/carcin\/bgab102 (2021).","journal-title":"Carcinogenesis"},{"key":"39106_CR17","doi-asserted-by":"publisher","first-page":"8349","DOI":"10.3892\/or.2022.8349","volume":"48","author":"A M\u00e9ndez-Clemente","year":"2022","unstructured":"M\u00e9ndez-Clemente, A. et al. Dual STAT-3 and IL-6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL-6\/IL-6R\/STAT-3 axis. Oncol. Rep. 48, 8349. https:\/\/doi.org\/10.3892\/or.2022.8349 (2022).","journal-title":"Oncol. Rep."},{"key":"39106_CR18","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. U. S. A. 117, 10970\u201310975. https:\/\/doi.org\/10.1073\/pnas.2005615117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"39106_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/ijc.29445","volume":"137","author":"FA Goumas","year":"2015","unstructured":"Goumas, F. A. et al. Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer. Int. J. Cancer 137, 1035\u20131046. https:\/\/doi.org\/10.1002\/ijc.29445 (2015).","journal-title":"Int. J. Cancer"},{"key":"39106_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/mc.22325","volume":"55","author":"N Yanaihara","year":"2016","unstructured":"Yanaihara, N. et al. Antitumor effects of interleukin-6 (IL-6)\/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary. Mol. Carcinog. 55, 832\u2013841. https:\/\/doi.org\/10.1002\/mc.22325 (2016).","journal-title":"Mol. Carcinog."},{"key":"39106_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","volume":"7","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis. Signal Transduct. Target. Ther. 7, 52. https:\/\/doi.org\/10.1038\/s41392-022-00872-9 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"39106_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jocn.2013.03.006","volume":"20","author":"RB Luwor","year":"2013","unstructured":"Luwor, R. B., Stylli, S. S. & Kaye, A. H. The role of Stat3 in glioblastoma multiforme. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Aust. 20, 907\u2013911. https:\/\/doi.org\/10.1016\/j.jocn.2013.03.006 (2013).","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Aust."},{"key":"39106_CR23","doi-asserted-by":"publisher","first-page":"421821","DOI":"10.1155\/2013\/421821","volume":"2013","author":"MZ Kamran","year":"2013","unstructured":"Kamran, M. Z., Patil, P. & Gude, R. P. Role of STAT3 in cancer metastasis and translational advances. Biomed. Res. Int. 2013, 421821. https:\/\/doi.org\/10.1155\/2013\/421821 (2013).","journal-title":"Biomed. Res. Int."},{"key":"39106_CR24","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3892\/ijo.2012.1568","volume":"41","author":"X Wang","year":"2012","unstructured":"Wang, X., Crowe, P. J., Goldstein, D. & Yang, J. L. STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int. J. Oncol. 41, 1181\u20131191. https:\/\/doi.org\/10.3892\/ijo.2012.1568 (2012).","journal-title":"Int. J. Oncol."},{"key":"39106_CR25","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/01.cco.0000432528.88101.1a","volume":"25","author":"JE Yeh","year":"2013","unstructured":"Yeh, J. E., Toniolo, P. A. & Frank, D. A. Targeting transcription factors: Promising new strategies for cancer therapy. Curr. Opin. Oncol. 25, 652\u2013658. https:\/\/doi.org\/10.1097\/01.cco.0000432528.88101.1a (2013).","journal-title":"Curr. Opin. Oncol."},{"key":"39106_CR26","first-page":"20014","volume":"8","author":"S He","year":"2015","unstructured":"He, S. et al. Overexpression of STAT3\/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis. Int. J. Clin. Exp. Med. 8, 20014\u201320023 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"39106_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0022-1759(98)00077-5","volume":"216","author":"R Verma","year":"1998","unstructured":"Verma, R., Boleti, E. & George, A. J. T. Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems. J. Immunol. Methods 216, 165\u2013181. https:\/\/doi.org\/10.1016\/S0022-1759(98)00077-5 (1998).","journal-title":"J. Immunol. Methods"},{"key":"39106_CR28","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s10529-014-1699-7","volume":"37","author":"S Fahad","year":"2014","unstructured":"Fahad, S. et al. Recent developments in therapeutic protein expression technologies in plants. Biotechnol. Letters 37, 1699. https:\/\/doi.org\/10.1007\/s10529-014-1699-7 (2014).","journal-title":"Biotechnol. Letters"},{"key":"39106_CR29","doi-asserted-by":"publisher","first-page":"9070842","DOI":"10.3390\/plants9070842","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B. & Phoolcharoen, W. Plant molecular farming: A viable platform for recombinant biopharmaceutical production. Plants Basel 9, 9070842. https:\/\/doi.org\/10.3390\/plants9070842 (2020).","journal-title":"Plants Basel"},{"key":"39106_CR30","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5681\/apb.2013.042","volume":"3","author":"KH Khan","year":"2013","unstructured":"Khan, K. H. Gene expression in mammalian cells and its applications. Adv. Pharm. Bull. 3, 257\u2013263. https:\/\/doi.org\/10.5681\/apb.2013.042 (2013).","journal-title":"Adv. Pharm. Bull."},{"key":"39106_CR31","doi-asserted-by":"publisher","first-page":"907175","DOI":"10.1080\/10826068.2014.907175","volume":"45","author":"N Abd El-Baky","year":"2014","unstructured":"Abd El-Baky, N. & Redwan, E. Therapeutic alpha-interferons protein: Structure, production, and biosimilar. Prep. Biochem. Biotechnol. 45, 907175. https:\/\/doi.org\/10.1080\/10826068.2014.907175 (2014).","journal-title":"Prep. Biochem. Biotechnol."},{"key":"39106_CR32","doi-asserted-by":"publisher","first-page":"4216060","DOI":"10.1155\/2019\/4216060","volume":"2019","author":"B Owczarek","year":"2019","unstructured":"Owczarek, B., Gerszberg, A. & Hnatuszko-Konka, K. A brief reminder of systems of production and chromatography-based recovery of recombinant protein biopharmaceuticals. Biomed. Res. Int. 2019, 4216060. https:\/\/doi.org\/10.1155\/2019\/4216060 (2019).","journal-title":"Biomed. Res. Int."},{"key":"39106_CR33","doi-asserted-by":"publisher","first-page":"306164","DOI":"10.1155\/2015\/306164","volume":"2015","author":"G Moussavou","year":"2015","unstructured":"Moussavou, G., Ko, K., Lee, J. H. & Choo, Y. K. Production of monoclonal antibodies in plants for cancer immunotherapy. Biomed. Res. Int. 2015, 306164. https:\/\/doi.org\/10.1155\/2015\/306164 (2015).","journal-title":"Biomed. Res. Int."},{"key":"39106_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.5511\/plantbiotechnology.21.0610a","volume":"38","author":"S Nosaki","year":"2021","unstructured":"Nosaki, S., Hoshikawa, K., Ezura, H. & Miura, K. Transient protein expression systems in plants and their applications. Plant Biotechnol. Tokyo 38, 297\u2013304. https:\/\/doi.org\/10.5511\/plantbiotechnology.21.0610a (2021).","journal-title":"Plant Biotechnol. Tokyo"},{"key":"39106_CR35","doi-asserted-by":"publisher","first-page":"589995","DOI":"10.3389\/fpls.2020.589995","volume":"11","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj, B., Rattanapisit, K., Manopwisedjaroen, S., Thitithanyanont, A. & Phoolcharoen, W. Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro. Front. Plant Sci. 11, 589995. https:\/\/doi.org\/10.3389\/fpls.2020.589995 (2020).","journal-title":"Front. Plant Sci."},{"key":"39106_CR36","doi-asserted-by":"publisher","first-page":"e037588","DOI":"10.1136\/bmjopen-2020-037588","volume":"10","author":"N Kittiratchakool","year":"2020","unstructured":"Kittiratchakool, N. et al. Cost-utility and budget impact analysis of tocilizumab for the treatment of refractory systemic juvenile idiopathic arthritis in Thailand. BMJ Open 10, e037588. https:\/\/doi.org\/10.1136\/bmjopen-2020-037588 (2020).","journal-title":"BMJ Open"},{"key":"39106_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41591-018-0041-7","volume":"24","author":"T Giavridis","year":"2018","unstructured":"Giavridis, T. et al. CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade. Nat. Med. 24, 731\u2013738. https:\/\/doi.org\/10.1038\/s41591-018-0041-7 (2018).","journal-title":"Nat. Med."},{"key":"39106_CR38","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang, C., Wu, Z., Li, J. W., Zhao, H. & Wang, G. Q. Cytokine release syndrome in severe COVID-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int. J. Antimicrob. Agents 55, 105954. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105954 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"39106_CR39","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s40265-017-0829-7","volume":"77","author":"LJ Scott","year":"2017","unstructured":"Scott, L. J. Tocilizumab: A review in rheumatoid arthritis. Drugs 77, 1865\u20131879. https:\/\/doi.org\/10.1007\/s40265-017-0829-7 (2017).","journal-title":"Drugs"},{"key":"39106_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","volume":"15","author":"C Kotch","year":"2019","unstructured":"Kotch, C., Barrett, D. & Teachey, D. T. Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome. Expert Rev. Clin. Immunol. 15, 813\u2013822. https:\/\/doi.org\/10.1080\/1744666X.2019.1629904 (2019).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"39106_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","volume":"384","author":"C Salama","year":"2020","unstructured":"Salama, C. et al. Tocilizumab in patients hospitalized with Covid-19 pneumonia. N. Engl. J. Med. 384, 20\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2030340 (2020).","journal-title":"N. Engl. J. Med."},{"key":"39106_CR42","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1093\/cid\/ciab409","volume":"73","author":"P Sinha","year":"2021","unstructured":"Sinha, P. & Linas, B. P. Combination therapy with tocilizumab and dexamethasone cost-effectively reduces coronavirus disease 2019 mortality. Clin. Infect. Dis. 73, 2116\u20132118. https:\/\/doi.org\/10.1093\/cid\/ciab409 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"39106_CR43","unstructured":"Zhang, N. & An, Z. In Manual of Industrial Microbiology and Biotechnology 145\u2013156 (2010)."},{"key":"39106_CR44","doi-asserted-by":"crossref","unstructured":"Pratheesh, P. T. & Vineetha, M. In Handbook of Marine Microalgae (ed Se-Kwon Kim) 415\u2013427 (Academic Press, 2015).","DOI":"10.1016\/B978-0-12-800776-1.00027-3"},{"key":"39106_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/plants9010030","volume":"9","author":"K-B Moon","year":"2019","unstructured":"Moon, K.-B. et al. Development of systems for the production of plant-derived biopharmaceuticals. Plants 9, 30 (2019).","journal-title":"Plants"},{"key":"39106_CR46","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/bab.1823","volume":"67","author":"A Siddiqui","year":"2019","unstructured":"Siddiqui, A., Wei, Z., Boehm, M. & Ahmad, N. Engineering microalgae through chloroplast transformation to produce high-value industrial products. Biotechnol. Appl. Biochem. 67, 1823. https:\/\/doi.org\/10.1002\/bab.1823 (2019).","journal-title":"Biotechnol. Appl. Biochem."},{"key":"39106_CR47","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/pbi.13657","volume":"19","author":"M Lobato G\u00f3mez","year":"2021","unstructured":"Lobato G\u00f3mez, M. et al. Contributions of the international plant science community to the fight against human infectious diseases\u2014Part 1: epidemic and pandemic diseases. Plant Biotechnol. J. 19, 1901\u20131920. https:\/\/doi.org\/10.1111\/pbi.13657 (2021).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR48","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/pbi.13658","volume":"19","author":"W He","year":"2021","unstructured":"He, W. et al. Contributions of the international plant science community to the fight against infectious diseases in humans\u2014part 2: Affordable drugs in edible plants for endemic and re-emerging diseases. Plant Biotechnol. J. 19, 1921\u20131936. https:\/\/doi.org\/10.1111\/pbi.13658 (2021).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.copbio.2019.11.002","volume":"61","author":"F Sainsbury","year":"2020","unstructured":"Sainsbury, F. Innovation in plant-based transient protein expression for infectious disease prevention and preparedness. Curr. Opin. Biotechnol. 61, 110\u2013115. https:\/\/doi.org\/10.1016\/j.copbio.2019.11.002 (2020).","journal-title":"Curr. Opin. Biotechnol."},{"key":"39106_CR50","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1016\/j.vaccine.2021.07.039","volume":"39","author":"N Kurokawa","year":"2021","unstructured":"Kurokawa, N. et al. Development and characterization of a plant-derived rotavirus-like particle vaccine. Vaccine 39, 4979\u20134987. https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.039 (2021).","journal-title":"Vaccine"},{"key":"39106_CR51","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1055\/s-0043-103964","volume":"83","author":"JH Ha","year":"2017","unstructured":"Ha, J. H. et al. Recombinant human acidic fibroblast growth factor (aFGF) expressed in Nicotiana benthamiana potentially inhibits skin photoaging. Planta Med. 83, 862\u2013869. https:\/\/doi.org\/10.1055\/s-0043-103964 (2017).","journal-title":"Planta Med."},{"key":"39106_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chroma.2015.02.013","volume":"1389","author":"A Fulton","year":"2015","unstructured":"Fulton, A., Lai, H., Chen, Q. & Zhang, C. Purification of monoclonal antibody against Ebola GP1 protein expressed in Nicotiana benthamiana. J. Chromatogr. A 1389, 128\u2013132. https:\/\/doi.org\/10.1016\/j.chroma.2015.02.013 (2015).","journal-title":"J. Chromatogr. A"},{"key":"39106_CR53","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/pbi.12378","volume":"14","author":"C Marusic","year":"2016","unstructured":"Marusic, C. et al. Production of an active anti-CD20-hIL-2 immunocytokine in Nicotiana benthamiana. Plant Biotechnol. J. 14, 240\u2013251. https:\/\/doi.org\/10.1111\/pbi.12378 (2016).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR54","doi-asserted-by":"publisher","first-page":"736299","DOI":"10.3389\/fpls.2021.736299","volume":"12","author":"T Phakham","year":"2021","unstructured":"Phakham, T. et al. Functional characterization of pembrolizumab produced in Nicotiana benthamiana using a rapid transient expression system. Front. Plant Sci. 12, 736299. https:\/\/doi.org\/10.3389\/fpls.2021.736299 (2021).","journal-title":"Front. Plant Sci."},{"key":"39106_CR55","doi-asserted-by":"publisher","DOI":"10.1055\/a-2076-2034","author":"B Shanmugaraj","year":"2023","unstructured":"Shanmugaraj, B., Jirarojwattana, P. & Phoolcharoen, W. Molecular farming strategy for the rapid production of protein-based reagents for use in infectious disease diagnostics. Planta Med. https:\/\/doi.org\/10.1055\/a-2076-2034 (2023).","journal-title":"Planta Med."},{"key":"39106_CR56","doi-asserted-by":"publisher","first-page":"e0274737","DOI":"10.1371\/journal.pone.0274737","volume":"17","author":"T Phetphoung","year":"2022","unstructured":"Phetphoung, T. et al. Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition. PLOS ONE 17, e0274737. https:\/\/doi.org\/10.1371\/journal.pone.0274737 (2022).","journal-title":"PLOS ONE"},{"key":"39106_CR57","doi-asserted-by":"publisher","first-page":"1012583","DOI":"10.3389\/fpls.2022.1012583","volume":"13","author":"O Hanittinan","year":"2022","unstructured":"Hanittinan, O. et al. Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies. Front. Plant Sci. 13, 1012583. https:\/\/doi.org\/10.3389\/fpls.2022.1012583 (2022).","journal-title":"Front. Plant Sci."},{"key":"39106_CR58","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/pbi.13040","volume":"17","author":"MR Islam","year":"2019","unstructured":"Islam, M. R. et al. Cost-effective production of tag-less recombinant protein in Nicotiana benthamiana. Plant Biotechnol. J. 17, 1094\u20131105. https:\/\/doi.org\/10.1111\/pbi.13040 (2019).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR59","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12896-016-0302-9","volume":"16","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. Plant expression of cocaine hydrolase-Fc fusion protein for treatment of cocaine abuse. BMC Biotechnol. 16, 72. https:\/\/doi.org\/10.1186\/s12896-016-0302-9 (2016).","journal-title":"BMC Biotechnol."},{"key":"39106_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/aac.00592-10","volume":"55","author":"KL Wycoff","year":"2011","unstructured":"Wycoff, K. L. et al. Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax. Antimicrob. Agents Chemother. 55, 132\u2013139. https:\/\/doi.org\/10.1128\/aac.00592-10 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"39106_CR61","first-page":"87","volume":"5","author":"S Akbarzadeh-Sharbaf","year":"2013","unstructured":"Akbarzadeh-Sharbaf, S., Yakhchali, B., Minuchehr, Z., Shokrgozar, M. A. & Zeinali, S. Expression enhancement in trastuzumab therapeutic monoclonal antibody production using genomic amplification with methotrexate. Avicenna J. Med. Biotechnol. 5, 87\u201395 (2013).","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"39106_CR62","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/19420862.2015.1008351","volume":"7","author":"J Chng","year":"2015","unstructured":"Chng, J. et al. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells. MAbs 7, 403\u2013412. https:\/\/doi.org\/10.1080\/19420862.2015.1008351 (2015).","journal-title":"MAbs"},{"key":"39106_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jbiotec.2020.09.006","volume":"324","author":"R Hoseinpoor","year":"2020","unstructured":"Hoseinpoor, R., Kazemi, B., Rajabibazl, M. & Rahimpour, A. Improving the expression of anti-IL-2R\u03b1 monoclonal antibody in the CHO cells through optimization of the expression vector and translation efficiency. J. Biotechnol. 324, 112\u2013120. https:\/\/doi.org\/10.1016\/j.jbiotec.2020.09.006 (2020).","journal-title":"J. Biotechnol."},{"key":"39106_CR64","doi-asserted-by":"publisher","first-page":"1112349","DOI":"10.3389\/fbioe.2023.1112349","volume":"11","author":"K Liang","year":"2023","unstructured":"Liang, K., Luo, H. & Li, Q. Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies. Front. Bioeng. Biotechnol. 11, 1112349. https:\/\/doi.org\/10.3389\/fbioe.2023.1112349 (2023).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"39106_CR65","doi-asserted-by":"publisher","first-page":"e0198978","DOI":"10.1371\/journal.pone.0198978","volume":"13","author":"I Song","year":"2018","unstructured":"Song, I., Kang, Y., Lee, Y. K., Myung, S. C. & Ko, K. Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17\u20131A affects mAb expression and plant stress response. PLoS One 13, e0198978. https:\/\/doi.org\/10.1371\/journal.pone.0198978 (2018).","journal-title":"PLoS One"},{"key":"39106_CR66","doi-asserted-by":"publisher","first-page":"21197007","DOI":"10.3390\/ijms21197007","volume":"21","author":"S Lim","year":"2020","unstructured":"Lim, S., Kim, D. S. & Ko, K. Expression of a large single-chain 13F6 antibody with binding activity against ebola virus-like particles in a plant system. Int. J. Mol. Sci. 21, 21197007. https:\/\/doi.org\/10.3390\/ijms21197007 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"39106_CR67","doi-asserted-by":"publisher","first-page":"770","DOI":"10.14348\/molcells.2021.2002","volume":"44","author":"I Song","year":"2021","unstructured":"Song, I. et al. Effect of an endoplasmic reticulum retention signal tagged to human anti-rabies mAb SO57 on its expression in arabidopsis and plant growth. Mol. Cells 44, 770\u2013779. https:\/\/doi.org\/10.14348\/molcells.2021.2002 (2021).","journal-title":"Mol. Cells"},{"key":"39106_CR68","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/plphys\/kiab102","volume":"186","author":"S Nosaki","year":"2021","unstructured":"Nosaki, S. et al. Prevention of necrosis caused by transient expression in Nicotiana benthamiana by application of ascorbic acid. Plant Physiol. 186, 832\u2013835. https:\/\/doi.org\/10.1093\/plphys\/kiab102 (2021).","journal-title":"Plant Physiol."},{"key":"39106_CR69","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/jxb\/49.326.1463","volume":"49","author":"C Rayon","year":"1998","unstructured":"Rayon, C., Lerouge, P. & Faye, L. The protein N-glycosylation in plants. J. Exp. Bot. 49, 1463\u20131472. https:\/\/doi.org\/10.1093\/jxb\/49.326.1463 (1998).","journal-title":"J. Exp. Bot."},{"key":"39106_CR70","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1467-7652.2008.00330.x","volume":"6","author":"R Strasser","year":"2008","unstructured":"Strasser, R. et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol. J. 6, 392\u2013402. https:\/\/doi.org\/10.1111\/j.1467-7652.2008.00330.x (2008).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR71","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","volume":"25","author":"D Reusch","year":"2015","unstructured":"Reusch, D. & Tejada, M. L. Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology 25, 1325\u20131334. https:\/\/doi.org\/10.1093\/glycob\/cwv065 (2015).","journal-title":"Glycobiology"},{"key":"39106_CR72","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/pbi.12416","volume":"13","author":"JK Ma","year":"2015","unstructured":"Ma, J. K. et al. Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants. Plant Biotechnol. J. 13, 1106\u20131120. https:\/\/doi.org\/10.1111\/pbi.12416 (2015).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR73","doi-asserted-by":"publisher","first-page":"e0216533","DOI":"10.1371\/journal.pone.0216533","volume":"14","author":"S Pillet","year":"2019","unstructured":"Pillet, S. et al. Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-two randomized Phase II clinical trials in 18 to 49 and \u226550 years old adults. PLoS One 14, e0216533. https:\/\/doi.org\/10.1371\/journal.pone.0216533 (2019).","journal-title":"PLoS One"},{"key":"39106_CR74","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1111\/pbi.12906","volume":"16","author":"A Castilho","year":"2018","unstructured":"Castilho, A. et al. An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana. Plant Biotechnol. J. 16, 1700\u20131709. https:\/\/doi.org\/10.1111\/pbi.12906 (2018).","journal-title":"Plant Biotechnol. J."},{"key":"39106_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2147\/oarrr.S17118","volume":"3","author":"M Mihara","year":"2011","unstructured":"Mihara, M., Ohsugi, Y. & Kishimoto, T. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis. Open Access Rheumatol. 3, 19\u201329. https:\/\/doi.org\/10.2147\/oarrr.S17118 (2011).","journal-title":"Open Access Rheumatol."},{"key":"39106_CR76","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.intimp.2005.05.010","volume":"5","author":"M Mihara","year":"2005","unstructured":"Mihara, M. et al. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Int. Immunopharmacol. 5, 1731\u20131740. https:\/\/doi.org\/10.1016\/j.intimp.2005.05.010 (2005).","journal-title":"Int. Immunopharmacol."},{"key":"39106_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jim.2009.10.002","volume":"352","author":"L Heinrich","year":"2010","unstructured":"Heinrich, L., Tissot, N., Hartmann, D. J. & Cohen, R. Comparison of the results obtained by ELISA and surface plasmon resonance for the determination of antibody affinity. J. Immunol. Methods 352, 13\u201322. https:\/\/doi.org\/10.1016\/j.jim.2009.10.002 (2010).","journal-title":"J. Immunol. Methods"},{"key":"39106_CR78","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/ajt.15712","volume":"20","author":"G Zhang","year":"2020","unstructured":"Zhang, G. et al. Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?. Am. J. Transplant. 20, 999\u20131013. https:\/\/doi.org\/10.1111\/ajt.15712 (2020).","journal-title":"Am. J. Transplant."},{"key":"39106_CR79","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-021-00764-4","volume":"6","author":"X Li","year":"2021","unstructured":"Li, X., Shao, M., Zeng, X., Qian, P. & Huang, H. Signaling pathways in the regulation of cytokine release syndrome in human diseases and intervention therapy. Signal Transduct. Target Ther. 6, 367. https:\/\/doi.org\/10.1038\/s41392-021-00764-4 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"39106_CR80","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1158\/1078-0432.Ccr-06-0861","volume":"12","author":"Z Duan","year":"2006","unstructured":"Duan, Z. et al. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 12, 5055\u20135063. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0861 (2006).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"39106_CR81","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/s0002-9440(10)61187-x","volume":"167","author":"Q Lin","year":"2005","unstructured":"Lin, Q. et al. Constitutive activation of JAK3\/STAT3 in colon carcinoma tumors and cell lines: Inhibition of JAK3\/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 167, 969\u2013980. https:\/\/doi.org\/10.1016\/s0002-9440(10)61187-x (2005).","journal-title":"Am. J. Pathol."},{"key":"39106_CR82","first-page":"978","volume":"57","author":"CI Sartor","year":"1997","unstructured":"Sartor, C. I., Dziubinski, M. L., Yu, C. L., Jove, R. & Ethier, S. P. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Can. Res. 57, 978\u2013987 (1997).","journal-title":"Can. Res."},{"key":"39106_CR83","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1038\/sj.onc.1206479","volume":"22","author":"L Song","year":"2003","unstructured":"Song, L., Turkson, J., Karras, J. G., Jove, R. & Haura, E. B. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22, 4150\u20134165. https:\/\/doi.org\/10.1038\/sj.onc.1206479 (2003).","journal-title":"Oncogene"},{"key":"39106_CR84","doi-asserted-by":"publisher","first-page":"760971","DOI":"10.3389\/fonc.2021.760971","volume":"11","author":"J Xu","year":"2021","unstructured":"Xu, J., Lin, H., Wu, G., Zhu, M. & Li, M. IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma. Front. Oncol. 11, 760971. https:\/\/doi.org\/10.3389\/fonc.2021.760971 (2021).","journal-title":"Front. Oncol."},{"key":"39106_CR85","doi-asserted-by":"publisher","first-page":"9111365","DOI":"10.3390\/vaccines9111365","volume":"9","author":"C Jugler","year":"2021","unstructured":"Jugler, C., Sun, H. & Chen, Q. SARS-CoV-2 spike protein-induced interleukin 6 signaling is blocked by a plant-produced anti-interleukin 6 receptor monoclonal antibody. Vaccines 9, 9111365. https:\/\/doi.org\/10.3390\/vaccines9111365 (2021).","journal-title":"Vaccines"},{"key":"39106_CR86","doi-asserted-by":"publisher","first-page":"4926168","DOI":"10.1155\/2017\/4926168","volume":"2017","author":"S Miao","year":"2017","unstructured":"Miao, S. et al. Physicochemical and biological characterization of the proposed biosimilar tocilizumab. Biomed. Res. Int. 2017, 4926168. https:\/\/doi.org\/10.1155\/2017\/4926168 (2017).","journal-title":"Biomed. Res. Int."}],"updated-by":[{"DOI":"10.1038\/s41598-023-41344-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39106-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T17:10:16Z","timestamp":1700241016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39106-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39106"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39106-5","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-023-41344-6","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-41344-6","URL":"https:\/\/doi.org\/10.1038\/s41598-023-41344-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.P. is a co-founder\/shareholder of Baiya Phytopharm Co., Ltd. Authors A.M. and K.R. have potential financial competing interest due to paid employment provided by Baiya Phytopharm Co., Ltd. The remaining authors (N.K., W.B., N.P., T.P., Ri.S., S.T., and Ra.S.) declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11927"}}